CIK 0001595097
- Non-accelerated filer
- Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464348039
- Phone
- +1 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,758,438
- in 2 filings, $16K under 10b5-1 plans
Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-22 | HOLMER ALAN F Director | Grant or award · Stock Option(right to buy) | +33,300 | 33,300 | ||
| 2019-05-22 | Hochman David P Director | Grant or award · Stock Option(right to buy) | +33,300 | 33,300 | ||
| 2019-05-22 | CATLIN AVERY W Director | Grant or award · Stock Option(right to buy) | +33,300 | 33,300 | ||
| 2019-05-17 | White Barbara Chief Medical Officer | Purchase | +1,389 | $7.20 | $10K | 185,548 |
| 2019-05-14 | Millian Craig Stuart Chief Commercial Officer | Purchase | +1,000 | $7.23 | $7K | 6,000 |
| 2019-05-14 | Moran Sean F. Chief Financial Officer | Purchase | +100 | $7.12 | $712 | 349,610 |
| 2019-05-13 | Cohen Yuval Chief Executive Officer | Purchase | +995 | $6.99 | $7K | 64,185 |
| 2019-04-05 | Jacques Rachelle Suzanne Director | Grant or award · Stock Option(right to buy) | +68,000 | 68,000 | ||
| 2019-03-15 | Hochman David P Director | Purchase | +2,000 | $6.98 | $14K | 7,000 |
| 2019-03-15 | Jenkins John Kenneth Director | Purchase | +1,000 | $6.98 | $7K | 1,000 |
| 2019-03-14 | Millian Craig Stuart Chief Commercial Officer | Purchase | +5,000 | $6.85 | $34K | 5,000 |
| 2019-03-14 | White Barbara Chief Medical Officer | Purchase | +4,638 | $6.47 | $30K | 184,159 |
| 2019-03-14 | Moran Sean F. Chief Financial Officer | Purchase | +1,500 | $6.67 | $10K | 349,510 |
| 2019-03-14 | Cohen Yuval Chief Executive Officer | Purchase | +1,530 | $6.49 | $10K | 63,190 |
| 2019-02-28 | Millian Craig Stuart Chief Commercial Officer | Grant or award · Stock Option(right to buy) | +180,000 | 180,000 | ||
| 2019-01-18 | Cohen Yuval Chief Executive Officer | Grant or award · Stock Option(right to buy) | +565,000 | 565,000 | ||
| 2019-01-18 | White Barbara Chief Medical Officer | Grant or award · Stock Option(right to buy) | +195,000 | 195,000 | ||
| 2019-01-18 | Tepper Mark President and CSO | Grant or award · Stock Option(right to buy) | +195,000 | 195,000 | ||
| 2019-01-18 | Moran Sean F. Chief Financial Officer | Grant or award · Stock Option(right to buy) | +195,000 | 195,000 | ||
| 2018-11-14 | Tepper Mark President and CSO | Exercise or conversion | +10,000 | $1.00 | $10K | 2,110,400 |
Page 14 of 16 · 320 trades